Erratum

Funding crunch forces stem cell company to abandon therapies (Nature Biotechnology (2007) 25, (951-952))

Monya Baker, Colin Pouton

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Number of pages1
JournalNature Biotechnology
Volume25
Issue number12
DOIs
Publication statusPublished - 1 Dec 2007

Cite this

@article{ce0ead2c3ed64fb2a881c8df55b2311d,
title = "Erratum: Funding crunch forces stem cell company to abandon therapies (Nature Biotechnology (2007) 25, (951-952))",
author = "Monya Baker and Colin Pouton",
year = "2007",
month = "12",
day = "1",
doi = "10.1038/nbt1207-1488a",
language = "English",
volume = "25",
journal = "Nature Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "12",

}

Erratum : Funding crunch forces stem cell company to abandon therapies (Nature Biotechnology (2007) 25, (951-952)). / Baker, Monya; Pouton, Colin.

In: Nature Biotechnology, Vol. 25, No. 12, 01.12.2007.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - Erratum

T2 - Funding crunch forces stem cell company to abandon therapies (Nature Biotechnology (2007) 25, (951-952))

AU - Baker, Monya

AU - Pouton, Colin

PY - 2007/12/1

Y1 - 2007/12/1

UR - http://www.scopus.com/inward/record.url?scp=36849090110&partnerID=8YFLogxK

U2 - 10.1038/nbt1207-1488a

DO - 10.1038/nbt1207-1488a

M3 - Comment / Debate

VL - 25

JO - Nature Biotechnology

JF - Nature Biotechnology

SN - 1087-0156

IS - 12

ER -